Enhanced hypoprothrombinemia with warfarin due to azithromycin

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 982-985

  Rao, Krishnamoorthy B ^a   Pallaki, Muralidhar ^b,c   Tolbert, Sandra R ^b,d,e   Hornick, Thomas R ^b,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TOLEDO   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Azithromycin; International normalized ratio; Prothrombin time; Warfarin

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CYTOCHROME P450; ERYTHROMYCIN; WARFARIN;

AFRICAN AMERICAN; AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; DRUG MONITORING; DRUG WITHDRAWAL; HUMAN; HYPOPROTHROMBINEMIA; INTERNATIONAL STANDARD UNIT; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; AZITHROMYCIN; DRUG INTERACTIONS; HUMANS; HYPOPROTHROMBINEMIAS; MALE; WARFARIN;

EID: 2442687143     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D489     Document Type: Article

References (26)

1. Package insert. Zithromax (azithromycin). New York: Pfizer Laboratories, August 2003.
2. Abramowicz M, ed. Drugs for AIDS and associated infections. Med Lett Drugs Ther 1995;37:87-94.
3. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91(suppl 3A):40S-5S.
4. Woldtvedt BR, Cahoon CL, Bradley LA, Miller SJ. Possible increased anticoagulation effect of warfarin induced by azithromycin (letter). Ann Pharmacother 1998;32:269-70. DOI 10.1345/aph.17165
5. Foster DR, Milan NL. Potential interaction between azithromycin and warfarin. Pharmacotherapy 1999;19:902-8.
6. Wiese MD, Cosh DG. Raised INR with concurrent warfarin and azithromycin. Aust J Hosp Pharm 1999;29:159-61.
7. Williams D, Ponte CD. Warfarin-associated hypoprothrombinemia: an unusual presentation. Am J Health Syst Pharm 2003;60:274-8.
8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
9. Hirsch J, Dalen J, Deykin D, Paller L, Bussey H. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(suppl):231S-46S.
10. Kaminski LS, Zhang Z. Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67-74.
11. Weibert RT, McQuade-Lorentz S, Townsend RJ, Cook CE, Klauber MR, Jagger PJ. Effect of erythromycin in patients receiving long-term warfarin therapy. Clin Pharm 1989;8:210-4.
12. Recker MW, Kier KL. Potential interaction between clarithromycin and warfarin. Ann Pharmacother 1997;31:996-8.
13. Oberg KC. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. Pharmacotherapy 1998;2:386-91.
14. Hassell D, Utt JK. Suspected interaction: warfarin and erythromycin. South Med J 1985;78:1015-6.
15. Husserl FE. Erythromycin-warfarin interaction (letter). Arch Intern Med 1983;143:1831-6.
16. Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-24.
17. Amacher DE, Schomaker SJ, Retsema JA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P450. Antimicrob Agents Chemother 1991;35:1186-90.
18. Beckey NP, Parra D, Colon A. Retrospective evaluation of potential interaction between azithromycin and warfarin in patients stabilized on warfarin. Pharmacotherapy 2000;20:1055-9.
19. Well PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
20. McNamara PJ, Trueb V, Stoeckel K. Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam. Biochem Pharmacol 1990;40:1247-53.
21. Hansten PD, Horns JR. Drug interactions: analysis and management. Vancouver, WA: Applied Therapeutics, 1998.
22. Udall JA. Human sources and absorption of vitamin K in relation to anticoagulation stability. JAMA 1965;194:107-9.
23. Serlin MJ, Breckenridge AM. Drug interactions with warfarin. Drugs 1983;25:610-20.
24. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(suppl A):73-82.
25. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2002:304.
26. Lane G. Increased hypoprothrombinemic effects of warfarin possibly induced by azithromycin (letter). Ann Pharmacother 1996;30:884-5.